Failure patterns and hazard rates for failure suggest the cure of prostate cancer by external beam radiation

Urology

Volumn 55, Issue 5, 2000, Pages 725-729

  Hanlon, Alexandra L ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; TIME; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT FAILURE;

EID: 0034186627     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00605-6     Document Type: Article

References (18)

1. Hanks GE: External beam radiation treatment for prostate cancer: the gold standard of treatment for 30 years. Oncology 6: 79-89, 1992.
2. Lee W, Hanks G, Hanlon A, et al. Rising PSA profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol 15: 230-238, 1997.
3. Kestin L, Vicini F, Ziaja E, et al: Defining biochemical cure for prostate cancer treated with external beam radiation therapy. Cancer 86: 1557-1566, 1999.
4. Crook J, Bahadur Y, Bociek R, et al: The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome assessed systematic biopsy and serum prostate specific antigen. Cancer 79: 81-89, 1997.
5. Pound C, Partin A, Eisenberger M, et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597, 1999.
6. Cox J, Grignon D, Kaplan R, et al: Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37: 1035-1041, 1997.
7. Fleming I, Cooper J, Henson D, et al (Eds): Prostate, in AJCC Cancer Staging Manual. Philadelphia, Lippincott-Raven, 1997, pp 219-224.
8. Hanks G, Schultheiss T, Price R, et al: Fox Chase Cancer Center: the Transition From 3D CRT to IMRT After Ten Years of Clinical Experience. International Symposium presented by Baylor College of Medicine, Houston, Texas, 1999.
9. Hanks GE, Schultheiss TE, Hanlon AL, et al: Dose escalation in the conformal treatment of prostate cancer: optimization is made possible by understanding the dose re-sponses for control of cancer and late morbidity. Int J Radiat Oncol Biol Phys 36: 197, 1996.
10. Hanks GE, Schultheiss TE, Hanlon AL, et al: Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study. Int J Radiat Oncol Biol Phys 37: 543-550, 1997.
11. International Commission on Radiation Units and Measurements: Prescribing, Recording, and Reporting Photon Beam Therapy. ICRU Report No. 50. Washington, DC, International Commission on Radiation Units and Measurements, 1993.
12. Kaplan EL, and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 447-457, 1958.
13. Lee E: Statistical Methods for Survival Data Analysis. Belmont, California, Lifetime Learning Publications, 1980, pp 9-74.
14. Hanlon A, and Hanks G: Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. Int J Radiat Oncol Biol Phys 46: 559-566, 2000.
15. Horwitz E, Vicini F, Ziaja E, et al: The correlation between the ASTRO consensus panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. Int J Radiat Oncol Biol Phys 41: 267-272, 1998.
16. Shipley W, Thames H, Sandler H, et al: Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281: 1558-1604, 1999.
17. Davis J, Kolm P, Wright G, et al: The durability of external beam radiation therapy for prostate cancer: can it be identified? J Urol 162: 758-761, 1999.
18. Dillioglugil O, Leibman B, Kattan M, et al: Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology 50: 93-99, 1997.